Business Context and Reporting Period
Company: MDxHealth SA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: April 2022
Date of Filing: April 27, 2022
Headquarters: Herstal, Belgium
This filing serves to furnish a press release issued by the Company on April 27, 2022, attached as Exhibit 99.1. The filing explicitly states that the information contained in the attached press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Key Financial Metrics
The provided text is a cover sheet for a Form 6-K and does not contain specific financial data. The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not disclose specific material changes in financial performance or operations versus the prior comparable period. It solely references the issuance of a press release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, or specific risk factors. It notes that the attached press release is furnished but not filed for liability purposes under the Exchange Act.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release dated April 27, 2022) for the actual content of the announcement, as the cover sheet contains no substantive details.
- Verify the legal status of the information, noting that the press release is not deemed "filed" under Section 18 of the Exchange Act.
- Confirm the identity of the signatory: Michael McGarrity, Chief Executive Officer.